Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Phys Rev Lett ; 131(2): 026601, 2023 Jul 14.
Article in English | MEDLINE | ID: mdl-37505946

ABSTRACT

While advances in electronic band theory have brought to light new topological systems, understanding the interplay of band topology and electronic interactions remains a frontier question. In this work, we predict new interacting electronic orders emerging near higher-order Van Hove singularities present in the Chern bands of the Haldane model. We classify the nature of such singularities and employ unbiased renormalization group methods that unveil a complex landscape of electronic orders, which include ferromagnetism, density waves, and superconductivity. Importantly, we show that repulsive interactions can stabilize the long-sought pair-density-wave state and an exotic Chern supermetal, which is a new class of non-Fermi liquid with anomalous quantum Hall response. This framework opens a new path to explore unconventional electronic phases in two-dimensional chiral bands through the interplay of band topology and higher-order Van Hove singularities.

2.
Nat Commun ; 13(1): 7785, 2022 Dec 16.
Article in English | MEDLINE | ID: mdl-36526619

ABSTRACT

Fractal Hofstadter bands have become widely accessible with the advent of moiré superlattices, opening the door to studies of the effect of interactions in these systems. In this work we employ a renormalization group (RG) analysis to demonstrate that the combination of repulsive interactions with the presence of a tunable manifold of Van Hove singularities provides a new mechanism for driving unconventional superconductivity in Hofstadter bands. Specifically, the number of Van Hove singularities at the Fermi energy can be controlled by varying the flux per unit cell and the electronic filling, leading to instabilities toward nodal superconductivity and chiral topological superconductivity with Chern number [Formula: see text]. The latter is characterized by a self-similar fixed trajectory of the RG flow and an emerging self-similarity symmetry of the order parameter. Our results establish Hofstadter quantum materials such as moiré heterostructures as promising platforms for realizing novel reentrant Hofstadter superconductors.

3.
Bio Protoc ; 10(17): e3742, 2020 Sep 05.
Article in English | MEDLINE | ID: mdl-33659402

ABSTRACT

An important but often overlooked aspect of gene regulation occurs at the level of protein translation. Many genes are regulated not only by transcription but by their propensity to be recruited to actively translating ribosomes (polysomes). Polysome profiling allows for the separation of unbound 40S and 60S subunits, 80S monosomes, and actively translating mRNA bound by two or more ribosomes. Thus, this technique allows for actively translated mRNA to be isolated. Transcript abundance can then be compared between actively translated mRNA and all mRNA present in a sample to identify instances of post-transcriptional regulation. Additionally, polysome profiling can be used as a readout of global translation rates by quantifying the proportion of actively translating ribosomes within a sample. Previously established protocols for polysome profiling rely on the absorbance of RNA to visualize the presence of polysomes within the fractions. However, with the advent of flow cells capable of detecting fluorescence, the association of fluorescently tagged proteins with polysomes can be detected and quantified in addition to the absorbance of RNA. This protocol provides detailed instructions on how to perform fluorescent polysome profiling in C. elegans to collect actively translated mRNA, to quantify changes in global translation, and to detect ribosomal binding partners.

4.
J Immunol ; 186(10): 5719-28, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21490154

ABSTRACT

We have previously shown that intranasal (i.n.) administration of a single MHC class II-restricted HY peptide to female mice induces tolerance to up to five additional epitopes expressed on test male grafts, a phenomenon known as linked suppression. In this study, we investigated the molecular mechanisms involved both in the induction phase following peptide administration and during linked suppression after grafting. We report that following initial i.n. administration, peptide is widely disseminated and is presented by functionally immature dendritic cells. These fail to cause optimal stimulation of the responding HY-specific CD4(+) T cells that express genes characteristic of regulatory T cells. Following i.n. peptide plus LPS administration, causing immunization, HY-specific CD4(+) T cells express genes characteristic of activated T cells. We further find that following male skin grafting, HY-specific CD8(+) T cells from peptide-treated tolerant mice display both quantitative and qualitative differences compared with similar cells from untreated mice that reject their grafts. In tolerant mice there are fewer HY-specific CD8(+) cells and they express several genes characteristic of exhausted T cells. Furthermore, associated with specific chemokine receptor and integrin expression, HY-specific CD8(+) T cells show more limited migration from the graft draining lymph node into other tissues.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Graft Survival/immunology , H-Y Antigen/immunology , Peptide Fragments/immunology , Transplantation Tolerance , Administration, Intranasal , Adoptive Transfer , Animals , Cell Movement , Cytokines/genetics , Dendritic Cells/immunology , Female , Flow Cytometry , Gene Expression , H-Y Antigen/administration & dosage , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/immunology , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Molecular Sequence Data , Peptide Fragments/administration & dosage , Polymerase Chain Reaction , Skin Transplantation/immunology
5.
Inflamm Bowel Dis ; 16(5): 765-75, 2010 May.
Article in English | MEDLINE | ID: mdl-19856416

ABSTRACT

BACKGROUND: The cytokine-deficiency-induced colitis susceptibility (Cdcs)1 locus is a major modifier of murine inflammatory bowel disease (IBD) and was originally identified in experimental crosses of interleukin-10-deficient (Il10(-/-)) mice. Congenic mice, in which this locus was reciprocally transferred between IBD-susceptible C3H/HeJBir-Il10(-/-) and resistant C57BL/6J-Il10(-/-) mice, revealed that this locus likely acts by inducing innate hypo- and adaptive hyperresponsiveness, associated with impaired NF-kappaB responses of macrophages. The aim of the present study was to dissect the complexity of Cdcs1 by further development and characterization of reciprocal Cdcs1 congenic strains and to identify potential candidate genes in the congenic interval. METHODS: In total, 15 reciprocal congenic strains were generated from Il10(-/-) mice of either C3H/HeJBir or C57BL/6J genetic backgrounds by 10 cycles of backcrossing. Colitis activity was monitored by histological grading. Candidate genes were identified by fine mapping of congenic intervals, sequencing, microarray analysis, and a high-throughput real-time reverse-transcription polymerase chain reaction (RT-PCR) approach using bone marrow-derived macrophages. RESULTS: Within the originally identified Cdcs1-interval, 3 independent regions were detected that likely contain susceptibility-determining genetic factors (Cdcs1.1, Cdcs1.2, and Cdcs1.3). Combining results of candidate gene approaches revealed Fcgr1, Cnn3, Larp7, and Alpk1 as highly attractive candidate genes with polymorphisms in coding or regulatory regions and expression differences between susceptible and resistant mouse strains. CONCLUSIONS: Subcongenic analysis of the major susceptibility locus Cdcs1 on mouse chromosome 3 revealed a complex genetic structure. Candidate gene approaches revealed attractive genes within the identified regions.


Subject(s)
Biomarkers, Tumor/genetics , Colitis/genetics , Genetic Predisposition to Disease , Interleukin-10/physiology , Animals , Biomarkers, Tumor/metabolism , Blotting, Western , Colitis/pathology , Female , Gene Expression Profiling , Male , Mice , Mice, Congenic , Mice, Inbred C3H , Mice, Inbred C57BL , NF-kappa B/metabolism , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
6.
Proc Natl Acad Sci U S A ; 106(5): 1518-23, 2009 Feb 03.
Article in English | MEDLINE | ID: mdl-19164519

ABSTRACT

Interleukin 21 (IL-21) is a pleiotropic cytokine produced by CD4 T cells that affects the differentiation and function of T, B, and NK cells by binding to a receptor consisting of the common cytokine receptor gamma chain and the IL-21 receptor (IL-21R). IL-21, a product associated with IL-17-producing CD4 T cells (T(H)17) and follicular CD4 T helper cells (T(FH)), has been implicated in autoimmune disorders including the severe systemic lupus erythematosus (SLE)-like disease characteristic of BXSB-Yaa mice. To determine whether IL-21 plays a significant role in this disease, we compared IL-21R-deficient and -competent BXSB-Yaa mice for multiple parameters of SLE. The deficient mice showed none of the abnormalities characteristic of SLE in IL-21R-competent Yaa mice, including hypergammaglobulinemia, autoantibody production, reduced frequencies of marginal zone B cells and monocytosis, renal disease, and premature morbidity. IL-21 production associated with this autoimmune disease was not a product of T(H)17 cells and was not limited to conventional CXCR5(+) T(FH) but instead was produced broadly by ICOS(+) CD4(+) splenic T cells. IL-21 arising from an abnormal population of CD4 T cells is thus central to the development of this lethal disease, and, more generally, could play an important role in human SLE and related autoimmune disorders.


Subject(s)
Lupus Erythematosus, Systemic/etiology , Receptors, Interleukin-21/metabolism , Signal Transduction , Animals , Antibody Formation , Base Sequence , DNA Primers , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Interleukins/genetics , Kidney Diseases/prevention & control , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/metabolism , Lymphocyte Subsets , Mice , Receptors, Interleukin-21/genetics
7.
Cancer Res ; 68(22): 9202-11, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-19010892

ABSTRACT

Aside from Myc-activating translocations characteristic of plasmacytomas (PCT), little is known about genetic factors and signaling pathways responsible for the development of spontaneous B-cell lineage lymphomas of mice. Here, we characterized the transcriptional profiles of PCT, centroblastic diffuse large B-cell lymphomas (CBL), and high-grade splenic marginal zone B-cell lymphoma (MZL++) using high-throughput quantitative reverse transcription-PCR. Expression profiles of CBL and MZL++ were strikingly similar and quite unlike that of PCT. Among the genes expressed at significantly higher levels by PCT were a number involved in NOTCH signaling, a finding supported by gene set enrichment analyses of microarray data. To investigate the importance of this pathway, NOTCH signaling was blocked in PCT cell lines by treatment with a gamma-secretase inhibitor (GSI) or transduction of a dominant-negative mutant of MAML1. These treatments resulted in reduced expression of NOTCH transcriptional targets in association with impaired proliferation and increased apoptosis. GSI treatment of transformed plasma cells in a primary PCT also induced apoptosis. These results integrate NOTCH activation with oncogenic signaling pathways downstream of translocated Myc in the pathogenesis of mouse PCT, two signaling pathways also implicated in development of human multiple myeloma and T-cell lymphoblastic lymphoma.


Subject(s)
Gene Expression Profiling , Lymphoma, B-Cell/pathology , Plasmacytoma/pathology , Receptors, Notch/physiology , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Animals , Cell Proliferation , Cell Survival , Lymphoma, B-Cell/etiology , Lymphoma, B-Cell/metabolism , Mice , Mice, Inbred BALB C , Oligonucleotide Array Sequence Analysis , Plasma Cells/metabolism , Plasmacytoma/etiology , Plasmacytoma/metabolism , Polymerase Chain Reaction , Receptors, Notch/antagonists & inhibitors , Signal Transduction
8.
Invest Ophthalmol Vis Sci ; 46(11): 4097-106, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16249486

ABSTRACT

PURPOSE: The present study was conducted to investigate healing of alkali-burned corneas in MRL/MpJ (MRL) mice. METHODS: Gross, clinical, and histologic criteria were used to compare healing of alkali-burned corneas in MRL and control C57BL/6J (B6) mice. Effects of neutrophil depletion of B6 mice and allogeneic reconstitution of B6 mice with MRL bone marrow on wound healing were evaluated. Gene expression patterns in normal and wounded corneas were surveyed with array-based quantitative real-time RT-PCR (AQPCR). RESULTS: MRL mice showed accelerated reepithelialization and decreased corneal opacity compared with B6 mice after alkali wounding. Marked inflammatory cell infiltration and fibrosis were evident in the corneas and anterior chambers of B6 mice. MRL mice showed less severe lesions, except for stromal edema. Rapid reepithelialization and reduced keratitis/iritis were also observed in neutrophil-depleted B6 mice, but not in B6 mice reconstituted with MRL bone marrow. AQPCR showed transcriptional changes of fewer genes associated with inflammation and corneal tissue homeostasis in alkali-burned corneas from MRL mice. Increased expression of an anti-inflammatory gene, Socs1, and a gene associated with healing, Mmp1a, were evident in MRL corneas. CONCLUSIONS: Alkali-burned corneas heal faster and more completely in MRL mice than in B6 mice, by means of rapid reepithelialization, reduced inflammation, and reduced fibrosis. Reduced inflammation, including decreased neutrophil infiltrates and the lack of a robust proinflammatory gene expression signature correlates with the rapid healing. However, the rapid-healing phenotype is not intrinsic to MRL hematopoietic progenitor cells.


Subject(s)
Burns, Chemical/metabolism , Corneal Diseases/metabolism , Eye Burns/chemically induced , Wound Healing/physiology , Animals , Bone Marrow Transplantation , Burns, Chemical/immunology , Burns, Chemical/pathology , Burns, Chemical/surgery , Carrier Proteins/genetics , Carrier Proteins/metabolism , Collagenases/genetics , Collagenases/metabolism , Corneal Diseases/immunology , Corneal Diseases/pathology , Corneal Diseases/surgery , Disease Models, Animal , Epithelium, Corneal/physiology , Flow Cytometry , Gene Expression Regulation/physiology , Male , Matrix Metalloproteinase 1 , Matrix Metalloproteinases/genetics , Matrix Metalloproteinases/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred MRL lpr , Neutrophils/physiology , Oligonucleotide Array Sequence Analysis , RNA, Messenger/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sodium Hydroxide , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism
9.
BMC Genet ; 6: 12, 2005 Mar 10.
Article in English | MEDLINE | ID: mdl-15760467

ABSTRACT

BACKGROUND: Recent developments in sequence databases provide the opportunity to relate the expression pattern of genes to their genomic position, thus creating a transcriptome map. Quantitative trait loci (QTL) are phenotypically-defined chromosomal regions that contribute to allelically variant biological traits, and by overlaying QTL on the transcriptome, the search for candidate genes becomes extremely focused. RESULTS: We used our novel data mining tool, ExQuest, to select genes within known diabesity QTL showing enriched expression in primary diabesity affected tissues. We then quantified transcripts in adipose, pancreas, and liver tissue from Tally Ho mice, a multigenic model for Type II diabetes (T2D), and from diabesity-resistant C57BL/6J controls. Analysis of the resulting quantitative PCR data using the Global Pattern Recognition analytical algorithm identified a number of genes whose expression is altered, and thus are novel candidates for diabesity QTL and/or pathways associated with diabesity. CONCLUSION: Transcription-based data mining of genes in QTL-limited intervals followed by efficient quantitative PCR methods is an effective strategy for identifying genes that may contribute to complex pathophysiological processes.


Subject(s)
Diabetes Mellitus, Type 2/genetics , Gene Expression Regulation , Quantitative Trait Loci , Algorithms , Animals , Humans , Mice , Mice, Inbred C57BL , Polymerase Chain Reaction , RNA, Messenger/analysis , Tissue Distribution
10.
J Immunol ; 174(3): 1196-204, 2005 Feb 01.
Article in English | MEDLINE | ID: mdl-15661873

ABSTRACT

NKT cell activation by alpha-galactosylceramide (alpha-GalCer) inhibits autoimmune diabetes in NOD mice, in part by inducing recruitment to pancreatic lymph nodes (PLNs) of mature dendritic cells (DCs) with disease-protective effects. However, how activated NKT cells promote DC maturation, and what downstream effect this has on diabetogenic T cells was unknown. Activated NKT cells were found to produce a soluble factor(s) inducing DC maturation. Initially, there was a preferential accumulation of mature DCs in the PLNs of alpha-GalCer-treated NOD mice, followed by a substantial increase in T cells. Adoptive transfer of a diabetogenic CD8 T cell population (AI4) induced a high rate of disease (75%) in PBS-treated NOD recipients, but not in those pretreated with alpha-GalCer (8%). Significantly, more AI4 T cells accumulated in PLNs of alpha-GalCer than PBS-treated recipients, while no differences were found in mesenteric lymph nodes from each group. Compared with those in mesenteric lymph nodes, AI4 T cells entering PLNs underwent greater levels of apoptosis, and the survivors became functionally anergic. NKT cell activation enhanced this process. Hence, activated NKT cells elicit diabetes protection in NOD mice by producing a soluble factor(s) that induces DC maturation and accumulation in PLNs, where they subsequently recruit and tolerize pathogenic T cells.


Subject(s)
Cell Movement/immunology , Dendritic Cells/immunology , Diabetes Mellitus, Type 1/prevention & control , Immune Tolerance , Killer Cells, Natural/immunology , Lymph Nodes/immunology , Lymphocyte Activation , Pancreas/immunology , T-Lymphocyte Subsets/immunology , Adjuvants, Immunologic/metabolism , Adjuvants, Immunologic/physiology , Animals , B-Lymphocyte Subsets/cytology , CD8-Positive T-Lymphocytes/cytology , Cell Aggregation/immunology , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Movement/genetics , Cell Proliferation , Cells, Cultured , Clone Cells , Dendritic Cells/cytology , Diabetes Mellitus, Type 1/immunology , Female , Galactosylceramides/administration & dosage , Galactosylceramides/pharmacology , Galactosylceramides/therapeutic use , Immune Tolerance/genetics , Killer Cells, Natural/cytology , Killer Cells, Natural/metabolism , Lymph Nodes/cytology , Lymphocyte Activation/genetics , Male , Mice , Mice, Inbred NOD , Mice, Knockout , Pancreas/cytology , Solubility , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/metabolism
11.
J Immunol ; 173(9): 5361-71, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15494482

ABSTRACT

IL-21 is a type I cytokine whose receptor is expressed on T, B, and NK cells. Within the B cell lineage, IL-21 regulates IgG1 production and cooperates with IL-4 for the production of multiple Ab classes in vivo. Using IL-21-transgenic mice and hydrodynamics-based gene delivery of IL-21 plasmid DNA into wild-type mice as well as in vitro studies, we demonstrate that although IL-21 induces death of resting B cells, it promotes differentiation of B cells into postswitch and plasma cells. Thus, IL-21 differentially influences B cell fate depending on the signaling context, explaining how IL-21 can be proapoptotic for B cells in vitro yet critical for Ag-specific Ig production in vivo. Moreover, we demonstrate that IL-21 unexpectedly induces expression of both Blimp-1 and Bcl-6, indicating mechanisms as to how IL-21 can serve as a complex regulator of B cell maturation and terminal differentiation. Finally, BXSB-Yaa mice, which develop a systemic lupus erythematosus-like disease, have greatly elevated IL-21, suggesting a role for IL-21 in the development of autoimmune disease.


Subject(s)
B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/immunology , DNA-Binding Proteins/biosynthesis , Interleukins/physiology , Plasma Cells/cytology , Plasma Cells/immunology , Proto-Oncogene Proteins/biosynthesis , Repressor Proteins/biosynthesis , Transcription Factors/biosynthesis , Animals , Apoptosis/genetics , Apoptosis/immunology , B-Lymphocyte Subsets/metabolism , Cell Division/genetics , Cell Division/immunology , Cell Separation , Cells, Cultured , DNA-Binding Proteins/antagonists & inhibitors , Humans , Immunoglobulin Class Switching/genetics , Interleukins/biosynthesis , Interleukins/genetics , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/immunology , Lymphocyte Count , Membrane Glycoproteins/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Mice, Transgenic , PAX5 Transcription Factor , Plasma Cells/metabolism , Positive Regulatory Domain I-Binding Factor 1 , Proteoglycans/biosynthesis , Proto-Oncogene Proteins c-bcl-6 , Spleen/anatomy & histology , Spleen/cytology , Spleen/immunology , Syndecans , Transcription Factors/antagonists & inhibitors , Up-Regulation/immunology
12.
J Clin Invest ; 113(9): 1328-33, 2004 May.
Article in English | MEDLINE | ID: mdl-15124024

ABSTRACT

The MHC class I family-like Fc receptor, FcRn, is normally responsible for extending the life span of serum IgG Ab's, but whether this molecule contributes to autoimmune pathogenesis remains speculative. To determine directly whether this function contributes to humoral autoimmune disease, we examined whether a deficiency in the FcRn heavy chain influences autoimmune arthritis in the K/BxN mouse model. FcRn deficiency conferred either partial or complete protection in the arthritogenic serum transfer and the more aggressive genetically determined K/BxN autoimmune arthritis models. The protective effects of an FcRn deficiency could be overridden with excessive amounts of pathogenic IgG Ab's. The therapeutic saturation of FcRn by high-dose intravenous IgG (IVIg) also ameliorated arthritis, directly implicating FcRn blockade as a significant mechanism of IVIg's anti-inflammatory action. The results suggest that FcRn is a potential therapeutic target that links the initiation and effector phases of humoral autoimmune disease.


Subject(s)
Autoimmune Diseases/etiology , Histocompatibility Antigens Class I/immunology , Immunoglobulin G/metabolism , Receptors, Fc/metabolism , Animals , Antibodies/blood , Antibodies/metabolism , Arthritis, Rheumatoid/etiology , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Disease Models, Animal , Dose-Response Relationship, Immunologic , Extremities/pathology , Female , Gene Expression Profiling , Heterozygote , Humans , Immunoglobulin G/administration & dosage , Immunoglobulin G/blood , Immunoglobulin G/pharmacology , Immunoglobulin G/therapeutic use , Injections, Intraperitoneal , Injections, Intravenous , Male , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Knockout , Mice, Transgenic , Receptors, Fc/deficiency , Receptors, Fc/genetics , Serum/metabolism , Transgenes
13.
Immunogenetics ; 55(5): 284-95, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12845499

ABSTRACT

Minor histocompatibility antigens (minor H antigen) elicit strong T-cell-mediated responses during both graft rejection and graft versus leukemia (GvL) among MHC-matched individuals (where MHC is major histocompatibility complex). Employing expression-cloning methodology, we have identified a cDNA clone, MI-35, encoding the immunodominant H4b minor H antigen within the classical mouse H4 complex. The minimal antigenic epitope derived from H4b presented on Kb class I MHC is SGIVYIHL (SYL8) and the polymorphism is due to C-->T nucleotide modification in p3 resulting in the change of threonine (ACT) to isoleucine (ATT). The results presented here demonstrate that amino acid variation in the allelic epitopes results in the low abundance of H4a peptide. The differential peptide copy number resulted in an immunodominant cytotoxic T cells (CTL) response directed against H4b while the anti-B6 response directed against H4a was easily dominated. These results provide a molecular mechanism for the H4 minor H antigen and suggest a novel mechanism by which alloantigenic disparity caused by conservative amino acid changes can be augmented by posttranslational antigen processing events.


Subject(s)
Membrane Glycoproteins/genetics , Minor Histocompatibility Antigens/genetics , Polymorphism, Single Nucleotide , Amino Acid Sequence , Animals , Base Sequence , Chromosome Mapping , DNA, Complementary , Epitopes , Isoantigens/genetics , Mice , Molecular Sequence Data
14.
Genome Res ; 13(7): 1719-27, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12840047

ABSTRACT

Description of the molecular phenotypes of pathobiological processes in vivo is a pressing need in genomic biology. We have implemented a high-throughput real-time PCR strategy to establish quantitative expression profiles of a customized set of target genes. It enables rapid, reproducible data acquisition from limited quantities of RNA, permitting serial sampling of mouse blood during disease progression. We developed an easy to use statistical algorithm--Global Pattern Recognition--to readily identify genes whose expression has changed significantly from healthy baseline profiles. This approach provides unique molecular signatures for rheumatoid arthritis, systemic lupus erythematosus, and graft versus host disease, and can also be applied to defining the molecular phenotype of a variety of other normal and pathological processes.


Subject(s)
Computational Biology/methods , Gene Expression Profiling/methods , Gene Expression Regulation/genetics , Oligonucleotide Array Sequence Analysis/methods , Algorithms , Animals , Arthritis, Rheumatoid/genetics , Computational Biology/statistics & numerical data , Disease Models, Animal , Disease Progression , Female , Gene Expression Profiling/statistics & numerical data , Genetic Predisposition to Disease/genetics , Graft vs Host Disease/genetics , Immunoassay/methods , Immunoassay/statistics & numerical data , Lupus Erythematosus, Systemic/genetics , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Models, Genetic , Models, Immunological , Oligonucleotide Array Sequence Analysis/statistics & numerical data , Phenotype , Reproducibility of Results , Sensitivity and Specificity
15.
J Immunol ; 170(7): 3528-33, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12646614

ABSTRACT

Abs of the IgG isotype are efficiently transported from mother to neonate and have an extended serum t(1/2) compared with Abs of other isotypes. Circumstantial evidence suggests that the MHC class I-related protein, the neonatal FcR (FcRn), is the FcR responsible for both in vivo functions. To understand the phenotypes imposed by FcRn, we produced and analyzed mice with a defective FcRn gene. The results provide direct evidence that perinatal IgG transport and protection of IgG from catabolism are mediated by FcRn, and that the latter function is key to IgG homeostasis, essential for generating a potent IgG response to foreign Ags, and the basis of enhanced efficacy of Fc-IgG-based therapeutics. FcRn is therefore a promising therapeutic target for enhancing protective humoral immunity, treating autoimmune disease, and improving drug efficacy.


Subject(s)
Animals, Newborn/immunology , CD40 Ligand/immunology , Histocompatibility Antigens Class I/physiology , Immune Sera/metabolism , Immunoconjugates/metabolism , Immunoglobulin G/metabolism , Receptors, Fc/metabolism , Receptors, IgG/physiology , Abatacept , Animals , Animals, Newborn/genetics , Animals, Newborn/growth & development , Crosses, Genetic , Female , Half-Life , Homeostasis/immunology , Humans , Immune Sera/administration & dosage , Immunity, Cellular/genetics , Immunoconjugates/administration & dosage , Immunoglobulin G/biosynthesis , Immunoglobulin G/blood , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/metabolism , Injections, Intraperitoneal , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Protein Transport/genetics , Protein Transport/immunology , Receptors, Fc/deficiency , Receptors, Fc/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...